Literature DB >> 27974545

The Ongoing Genetic Adaptation of Streptococcus pneumoniae.

Sandra S Richter1, Daniel M Musher2.   

Abstract

Streptococcus pneumoniae has demonstrated a remarkable ability to adapt during the conjugate vaccine era. The increasing incidence of serotype 35B disease and emergence of a multidrug-resistant clone reported in this issue of the Journal of Clinical Microbiology (L. Olarte et al., J Clin Microbiol 55:724-734, 2017, https://doi.org/10.1128/JCM.01778-16) underscore the limitations of pneumococcal vaccines that target the polysaccharide capsule.
Copyright © 2017 American Society for Microbiology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27974545      PMCID: PMC5328434          DOI: 10.1128/JCM.02283-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Authors:  G V Doern; K P Heilmann; H K Huynh; P R Rhomberg; S L Coffman; A B Brueggemann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  The Significance of Pneumococcal Types.

Authors:  F Griffith
Journal:  J Hyg (Lond)       Date:  1928-01

3.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

4.  Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.

Authors:  Sara Tomczyk; Ruth Lynfield; William Schaffner; Arthur Reingold; Lisa Miller; Susan Petit; Corinne Holtzman; Shelley M Zansky; Ann Thomas; Joan Baumbach; Lee H Harrison; Monica M Farley; Bernard Beall; Lesley McGee; Ryan Gierke; Tracy Pondo; Lindsay Kim
Journal:  Clin Infect Dis       Date:  2016-02-07       Impact factor: 9.079

5.  Emergence of multiply resistant pneumococci.

Authors:  M R Jacobs; H J Koornhof; R M Robins-Browne; C M Stevenson; Z A Vermaak; I Freiman; G B Miller; M A Witcomb; M Isaäcson; J I Ward; R Austrian
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

6.  Susceptibility of pneumococci to nine antibiotics.

Authors:  J W Kislak; L M Razavi; A K Daly; M Finland
Journal:  Am J Med Sci       Date:  1965-09       Impact factor: 2.378

7.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

8.  Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Authors:  Sandra S Richter; Daniel J Diekema; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

Review 9.  How effective is vaccination in preventing pneumococcal disease?

Authors:  Daniel M Musher
Journal:  Infect Dis Clin North Am       Date:  2013-03       Impact factor: 5.982

10.  PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.

Authors:  C M Macleod; R G Hodges; M Heidelberger; W G Bernhard
Journal:  J Exp Med       Date:  1945-11-30       Impact factor: 14.307

View more
  1 in total

1.  Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017.

Authors:  Kimiko Ubukata; Misako Takata; Miyuki Morozumi; Naoko Chiba; Takeaki Wajima; Shigeo Hanada; Michi Shouji; Megumi Sakuma; Satoshi Iwata
Journal:  Emerg Infect Dis       Date:  2018-11       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.